PLAY
Target
We target a metabolic feature of activated cancer and immune cells: their high cell surface acidity
PLAY
Deliver
Therapeutic and imaging agents are selectively delivered to acidic cells in diseased tissues by our proprietary pHLIP® Technology
PLAY
Cure
Cures can be enabled by marking acidic cells for surgical removal or by activation of an immune response
PLAY
Cure
Cures can be enabled by reprogramming acidic cells in diseased tissues
PLAY
Cure
Cures can be enabled by killing acidic cells in diseased tissues
PLAY

Our mission

Our mission is to improve patient outcomes and save lives using our peptide-based targeted delivery platform to cure cancer, inflammation and other acidic tissue diseases

what Is pHLIP®?

pHLIP® is a proprietary pH-Low Insertion Peptide Platform Technology for targeted delivery of therapeutics to acidic cells in diseased tissues
learn more
Go to next page
Bullet icon
pHLIP® peptides sense and target high cell surface acidity or low pH
Go to next page
Bullet icon 2
pHLIP® peptides tether therapeutic and imaging agents to acidic cells
Go to next page
Bullet icon 3
pHLIP® peptides flip cell-regulation agents directly into acidic cells
Go to next page
pHLIP® targeting improves therapeutic efficacy
and significantly reduces side effects